These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17685120

  • 1. Prognostic significance of EGFR, p53 and E-cadherin in mucoepidermoid cancer of the salivary glands: a retrospective case series.
    Hoyek-Gebeily J, Nehmé E, Aftimos G, Sader-Ghorra C, Sargi Z, Haddad A.
    J Med Liban; 2007; 55(2):83-8. PubMed ID: 17685120
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS, Bento MJ, Palmeira C, Lopes C.
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [Abstract] [Full Text] [Related]

  • 3. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
    Hoyek-Gebeily J, Nehmé E, Aftimos G, Sader-Ghorra C, Sargi Z, Haddad A.
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, Kondo Y, Nagao K.
    Cancer; 1998 Feb 01; 82(3):439-47. PubMed ID: 9452259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
    Khiavi MM, Vosoughhosseini S, Saravani S, Halimi M.
    J Cancer Res Ther; 2012 Feb 01; 8(4):586-90. PubMed ID: 23361279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG, Steiniche T, Overgaard J, Danish Head and Neck Cancer study group (DAHANCA).
    Acta Oncol; 2005 Feb 01; 44(1):50-8. PubMed ID: 15848906
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience.
    Aro K, Leivo I, Mäkitie AA.
    Laryngoscope; 2008 Feb 01; 118(2):258-62. PubMed ID: 18030166
    [Abstract] [Full Text] [Related]

  • 12. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
    da Cruz Perez DE, Pires FR, Alves FA, Almeida OP, Kowalski LP.
    Int J Pediatr Otorhinolaryngol; 2004 Jul 01; 68(7):895-902. PubMed ID: 15183580
    [Abstract] [Full Text] [Related]

  • 13. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE.
    Laryngoscope; 2001 Aug 01; 111(8):1373-8. PubMed ID: 11568571
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y, Zhou XY, Yao XD, Dai B, Ye DW.
    BJU Int; 2007 Jul 01; 100(1):204-8. PubMed ID: 17433031
    [Abstract] [Full Text] [Related]

  • 15. [Mucoepidermoid carcinomas of salivary glands: prognostic significance of immunohistochemistry. A study of 49 cases].
    Santini L, Coulibaly B, Gaudart J, Turner F, Michel J, Giovanni A, Dessi P, Fakhry N.
    Rev Laryngol Otol Rhinol (Bord); 2012 Jul 01; 133(4-5):183-7. PubMed ID: 24006824
    [Abstract] [Full Text] [Related]

  • 16. TNM staging, histopathological grading, and tumor-associated antigens in patients with a history of mucoepidermoid carcinoma of the salivary glands.
    Plambeck K, Friedrich RE, Bahlo M, Bartel-Friedrich S, Klapdor R.
    Anticancer Res; 1999 Jul 01; 19(4A):2397-404. PubMed ID: 10470165
    [Abstract] [Full Text] [Related]

  • 17. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients.
    Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD, Faratzis G, Lagogiannis GA, Katsilieris I, Patsouris E.
    Oral Oncol; 2007 Feb 01; 43(2):130-6. PubMed ID: 16857410
    [Abstract] [Full Text] [Related]

  • 18. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
    Weed DT, Gomez-Fernandez C, Pacheco J, Ruiz J, Hamilton-Nelson K, Arnold DJ, Civantos FJ, Zhang J, Yasin M, Goodwin WJ, Carraway KL.
    Head Neck; 2004 Apr 01; 26(4):353-64. PubMed ID: 15054739
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in head and neck mucoepidermoid carcinoma.
    Pires FR, de Almeida OP, de Araújo VC, Kowalski LP.
    Arch Otolaryngol Head Neck Surg; 2004 Feb 01; 130(2):174-80. PubMed ID: 14967746
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population.
    Liu S, Ow A, Ruan M, Yang W, Zhang C, Wang L, Zhang C.
    Int J Oral Maxillofac Surg; 2014 Jun 01; 43(6):667-73. PubMed ID: 24568836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.